3,359 findings · Energy balance · published 2017+
- Energy balanceStrong
The Shape intervention cost an average of US $758 per participant.
Practitioners can expect the intervention to have a specific cost per participant.
Supports 2018 - Energy balanceStrong
Das Programm ist aufgrund tiefer Gruppentarife der Krankenversicherer in der Schweiz für Anbieter nicht kostendeckend.
Anbieter sollten die wirtschaftlichen Aspekte des Programms berücksichtigen.
Refutes 2020 - Energy balanceStrong
Das Programm ist aufgrund tiefer Gruppentarife der Krankenversicherer in der Schweiz für Anbieter nicht kostendeckend.
Anbieter sollten die wirtschaftlichen Aspekte des Programms berücksichtigen.
Refutes 2022 - Energy balanceStrong
Participants expressed a strong social identity and belongingness to online zero-carb communities.
Encouraging community support may enhance adherence to zero-carb diets.
Supports 2020 - Energy balanceStrong
The dietary decision support system captures nutrient data in both English and Hindi.
Practitioners can utilize this system in diverse linguistic contexts to enhance user engagement.
Supports 2019 - Energy balanceStrong
Total protein and animal protein were not associated with all-cause, CVD, or cancer mortality.
Practitioners should note that total and animal protein intake does not impact mortality risk.
Refutes 2025New - Energy balanceStrong
58% of the adult population across OECD countries are overweight or obese.
Health professionals should be aware of the high prevalence of obesity in OECD countries.
Supports 2019 - Energy balanceStrong
Every dollar spent on preventing obesity generates an economic return of up to six dollars.
Investing in obesity prevention can be financially beneficial for policymakers.
Supports 2019 - Energy balanceStrong
The absolute number of deaths from CVD continues to increase, particularly in middle- and low-income countries.
Health interventions should prioritize middle- and low-income countries to address rising CVD deaths.
Supports 2017 - Energy balanceStrong
Reliable data to estimate CVD burden are lacking in many regions, hindering prevention and management strategies.
Efforts should be made to improve data collection for better CVD management strategies.
Supports 2017 - Energy balanceStrong
Four machine learning tasks are identified: regression, classification, recommendation, and clustering.
These tasks can guide researchers in selecting appropriate machine learning methods for their studies.
Supports 2021 - Energy balanceStrong
Classification systems for processed foods are ambiguous and inconsistent.
Practitioners should be cautious when using classification systems for processed foods due to their inconsistencies.
Refutes 2021 - Energy balanceStrong
There is no consensus on what factors determine the level of food processing.
Practitioners should recognize the variability in defining food processing levels.
Refutes 2021 - Energy balanceStrong
ASFs can play an important role in circular and diverse agroecosystems that can help restore biodiversity and mitigate greenhouse gas emissions.
Sustainable farming practices for ASFs should be promoted to enhance environmental benefits.
Supports 2023 - Energy balanceStrong
Naltrexone, bupropion, or their combination (B-N) is not associated with the incidence of major cardiovascular adverse events (MACE) compared with placebo.
Clinicians can consider that these treatments do not increase the risk of major cardiovascular events.
Refutes 2021 - Energy balanceStrong
The current evidence does not demonstrate Blautia’s direct involvement as a pathogenic microbe in obesity development or progression.
Practitioners should consider that Blautia may not be a direct target for obesity treatment based on current evidence.
Refutes 2024 - Energy balanceStrong
Islet autoantibodies were present in 6.4% of overweight/obese adults with type 2 diabetes.
Practitioners should be aware that a small percentage of overweight/obese adults with type 2 diabetes may have islet autoantibodies.
Supports 2018 - Energy balanceStrong
Access to new antiobesity medications is severely limited despite their potential to combat obesity.
Practitioners should be aware of the barriers to access for new antiobesity medications.
Supports 2022 - Energy balanceStrong
There are currently no completed randomized trials of physical activity where mortality is a prespecified primary outcome.
Current physical activity guidelines may lack robust evidence from randomized trials focused on mortality.
Supports 2018 - Energy balanceStrong
Increasing baseline blood-based biomarker levels were not associated with any cognitive composite z score.
Baseline BBM levels may not be useful for predicting cognitive function in this population.
Refutes 2025New - Energy balanceStrong
Existing data analytic methods for SMARTs are suitable only for superiority testing.
Current analytic methods need to be adapted for noninferiority/equivalence testing in SMARTs.
Supports 2019 - Energy balanceStrong
Approximately two-thirds of patients who achieved remission relapsed within 1 year.
Practitioners should prepare for potential relapse in patients post-remission.
Supports 2023 - Energy balanceStrong
Longitudinal studies of LIRE-BFR showed no changes in arterial stiffness in both young and older people.
Practitioners should note that LIRE-BFR may not affect arterial stiffness over the long term in their clients.
Refutes 2020 - Energy balanceStrong
Nutrition is relevant along the criminal justice continuum.
Nutrition should be integrated into discussions and interventions within the criminal justice system.
Supports 2024